Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Stream Connecticut News for free, 24/7, wherever you are. Drugmakers have poured billions of dollars into ...

From a chemistry, manufacturing, and controls (CMC) perspective, ADCs present unique hurdles. “ADCs introduce unique challenges across areas like process and purification development, analytical ...

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I clinical study (study code: JSKN027-101) of JSKN027, an independently developed ...

With thoracic oncology in the middle of a combinatorial revolution—EGFR-targeted doublets and triplets, a maturing ...

Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Drugmakers have poured billions of dollars into developing ADCs. The medicines are designed to deliver potent ...

But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects in some cases. Antibody-drug conjugates ...

The antibody guides the ADC to the cancer cell, and once inside, the linker releases the chemotherapy to kill the cancer from within. Newer ADCs leading the space, such as Enhertu from AstraZeneca and ...